Published in J Clin Psychopharmacol on June 01, 2017
Using the international 10-20 EEG system for positioning of transcranial magnetic stimulation. Brain Topogr (2003) 2.89
A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest (2004) 2.52
Chronic social stress inhibits cell proliferation in the adult medial prefrontal cortex: hemispheric asymmetry and reversal by fluoxetine treatment. Neuropsychopharmacology (2006) 1.72
Epileptic seizure following 1 Hz repetitive transcranial magnetic stimulation. Clin Neurophysiol (2006) 1.66
Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology (2005) 1.65
Investigating directed influences between activated brain areas in a motor-response task using fMRI. Magn Reson Imaging (2005) 1.61
Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. Brain (2007) 1.42
Concerns about pregabalin: further experience with its potential of causing addictive behaviors. J Addict Med (2013) 1.28
Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study. Am J Psychiatry (2008) 1.27
Mechanisms and applications of theta-burst rTMS on the human motor cortex. Brain Topogr (2009) 1.17
Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease. Exp Neurol (2008) 1.17
Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting. Eur J Clin Pharmacol (2004) 1.16
Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam. Behav Pharmacol (2008) 1.14
Pregabalin abuse and dependence in Germany: results from a database query. Eur J Clin Pharmacol (2013) 1.09
Better risk assessment for individual substances. Dtsch Arztebl Int (2015) 1.09
Electroconvulsive therapy in pregnancy revisited. Psychosom Med (2013) 1.08
Desomorphine goes "crocodile". J Addict Dis (2012) 1.08
Regional brain activation changes and abnormal functional connectivity of the ventrolateral prefrontal cortex during working memory processing in adults with attention-deficit/hyperactivity disorder. Hum Brain Mapp (2009) 1.06
Citalopram counteracts depressive-like symptoms evoked by chronic social stress in rats. Behav Pharmacol (2006) 1.04
Effects of fluoxetine on behavioral deficits evoked by chronic social stress in rats. Behav Brain Res (2006) 1.03
Add-on rTMS for treatment of depression: a pilot study using stereotaxic coil-navigation according to PET data. J Psychiatr Res (2003) 1.02
Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression. Neuropharmacology (2011) 1.00
Dysconnectivity of multiple resting-state networks in patients with schizophrenia who have persistent auditory verbal hallucinations. J Psychiatry Neurosci (2011) 0.98
The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.98
Side effects of transcranial magnetic stimulation biased task performance in a cognitive neuroscience study. Brain Topogr (2005) 0.95
Cortical dysfunction in patients with Huntington's disease during working memory performance. Hum Brain Mapp (2009) 0.94
The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia. Neuropsychopharmacology (2006) 0.93
Quantification of D2-like dopamine receptors in the human brain with 18F-desmethoxyfallypride. J Nucl Med (2003) 0.93
Effect of chronic citalopram on serotonin-related and stress-regulated genes in the dorsal raphe nucleus of the rat. Eur Neuropsychopharmacol (2006) 0.93
Delusional infestation: neural correlates and antipsychotic therapy investigated by multimodal neuroimaging. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.93
Free-choice ethanol consumption under the influence of GABAergic drugs in rats. Alcohol Clin Exp Res (2002) 0.93
Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetine. Neurosci Lett (2002) 0.92
Primary delusional parasitosis treated with olanzapine. Int Psychogeriatr (2007) 0.90
Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds--implications for pharmacokinetics of selected substrates. J Pharm Pharmacol (2004) 0.90
Over-expression of two different forms of the alpha-secretase ADAM10 affects learning and memory in mice. Behav Brain Res (2006) 0.90
Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand? Eur Arch Psychiatry Clin Neurosci (2011) 0.90
Chronic lithium salt treatment reduces CRE/CREB-directed gene transcription and reverses its upregulation by chronic psychosocial stress in transgenic reporter gene mice. Neuropsychopharmacology (2007) 0.89
Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effects. World J Biol Psychiatry (2008) 0.89
Chronic psychosocial stress and citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampus. Psychopharmacology (Berl) (2012) 0.89
Delusional parasitosis and the matchbox sign revisited: the international perspective. Acta Derm Venereol (2010) 0.88
Cerebral Amyloidal Angiopathy--a disease with implications for neurology and psychiatry. Brain Res (2013) 0.88
Tyrosine hydroxylase Val-81-Met polymorphism associated with early-onset alcoholism. Psychiatr Genet (2005) 0.87
Hormonal influences on cardiovascular norepinephrine transporter responses in healthy women. Hypertension (2008) 0.86
Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism. World J Biol Psychiatry (2007) 0.86
Sensorimotor memory for fingertip forces during object lifting: the role of the primary motor cortex. Neuropsychologia (2007) 0.86
The chronic psychosocial stress paradigm in male tree shrews: evaluation of a novel animal model for depressive disorders. Stress (2002) 0.86
Spatial congruence of neuronavigated transcranial magnetic stimulation and functional neuroimaging. Clin Neurophysiol (2002) 0.86
Intracortical excitability is modulated by a norepinephrine-reuptake inhibitor as measured with paired-pulse transcranial magnetic stimulation. Psychopharmacology (Berl) (2002) 0.86
Blood-brain barrier penetration of the enantiomers of venlafaxine and its metabolites in mice lacking P-glycoprotein. Eur Neuropsychopharmacol (2010) 0.86
Cortical activation during a pitch discrimination task in tinnitus patients and controls--an fMRI study. Audiol Neurootol (2009) 0.85
Pharmacodynamic consequences of P-glycoprotein-dependent pharmacokinetics of risperidone and haloperidol in mice. Behav Brain Res (2007) 0.85
Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone). J Clin Psychopharmacol (2008) 0.85
Appropriateness of therapeutic drug monitoring for antidepressants in routine psychiatric inpatient care. Ther Drug Monit (2006) 0.84
The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants. Dialogues Clin Neurosci (2005) 0.84
Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study. Psychopharmacology (Berl) (2009) 0.84
Serotonin syndrome as a result of fluoxetine in a patient with tramadol abuse: plasma level-correlated symptomatology. J Clin Psychopharmacol (2002) 0.84
Paliperidone extended-release: does it have a place in antipsychotic therapy? Drug Des Devel Ther (2011) 0.84
Therapeutic monitoring of aripiprazole by HPLC with column-switching and spectrophotometric detection. Clin Chem (2005) 0.84
Toxic clozapine serum levels during inflammatory reactions. J Clin Psychopharmacol (2009) 0.84
Sham or real--post hoc estimation of stimulation condition in a randomized transcranial magnetic stimulation trial. Neurosci Lett (2010) 0.83
The Acid Sphingomyelinase Sequence Variant p.A487V Is Not Associated With Decreased Levels of Enzymatic Activity. JIMD Rep (2012) 0.83
Therapeutic drug monitoring for drugs used in the treatment of substance-related disorders: literature review using a therapeutic drug monitoring appropriateness rating scale. Ther Drug Monit (2011) 0.83
High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia. Int J Neuropsychopharmacol (2004) 0.83
Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas. Int J Neuropsychopharmacol (2010) 0.82
Self-mutilation induced by psychotropic substances: a systematic review. Psychiatry Res (2012) 0.82
Serotonergic modulation of response inhibition and re-engagement? Results of a study in healthy human volunteers. Hum Psychopharmacol (2010) 0.82
Continuous theta-burst stimulation over the dorsal premotor cortex interferes with associative learning during object lifting. Cortex (2008) 0.82
Ziprasidone in Parkinson's disease psychosis. Can J Psychiatry (2004) 0.82
Determination of citalopram and escitalopram together with their active main metabolites desmethyl(es-)citalopram in human serum by column-switching high performance liquid chromatography (HPLC) and spectrophotometric detection. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.81
Serum concentrations of paliperidone versus risperidone and clinical effects. Eur J Clin Pharmacol (2010) 0.81
Wilson's disease in psychiatric patients. Psychiatry Clin Neurosci (2002) 0.81
Population pharmacokinetic analysis of mirtazapine. Eur J Clin Pharmacol (2004) 0.81
Low novelty seeking and high self directedness scores in alcohol-dependent patients without comorbid psychiatric disorders homozygous for the A10 allele of the dopamine transporter gene. World J Biol Psychiatry (2010) 0.81
Effects of escitalopram on the regulation of brain-derived neurotrophic factor and nerve growth factor protein levels in a rat model of chronic stress. J Neurosci Res (2009) 0.81
Potential cost-effectiveness of therapeutic drug monitoring for depressed patients treated with citalopram. Ther Drug Monit (2013) 0.81
Serum concentrations of hydroxybupropion for dose optimization of depressed patients treated with bupropion. Ther Drug Monit (2014) 0.80
Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine. Psychoneuroendocrinology (2005) 0.80
Automated determination of ziprasidone by HPLC with column switching and spectrophotometric detection. Ther Drug Monit (2005) 0.80
Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene. Clin Biochem (2009) 0.80
Effects of antipsychotic treatment on cognition in healthy subjects. J Psychopharmacol (2012) 0.80
Automated analysis of quetiapine and other antipsychotic drugs in human blood by high performance-liquid chromatography with column-switching and spectrophotometric detection. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.80
Transcranial magnetic stimulation in the reversal of motor conversion disorder. Psychother Psychosom (2003) 0.80
Therapeutic drug monitoring of the antidepressant mirtazapine and its N-demethylated metabolite in human serum. Ther Drug Monit (2004) 0.79
Schizophrenic patients who smoke have a faster finger tapping rate than non-smokers. Eur Neuropsychopharmacol (2002) 0.79
The use of ziprasidone in clinical practice: analysis of pharmacokinetic and pharmacodynamic aspects from data of a drug monitoring survey. Eur Psychiatry (2008) 0.79
Transcranial magnetic stimulation in motor conversion disorder: a short case series. J Clin Neurophysiol (2006) 0.79
Large variability of aripiprazole and dehydroaripiprazole serum concentrations in adolescent patients with schizophrenia. Ther Drug Monit (2008) 0.79
Exploring the affective component of pain perception during aversive stimulation in borderline personality disorder. Psychiatry Res (2010) 0.79
Aripiprazole and Parkinson's disease psychosis. Am J Psychiatry (2004) 0.79